AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19023899
Drug: Scheduled maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled maintenance therapy (group A) - IFX every 2 months
Trial: 19023899
Drug: On demand
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On demand maintenance therapy (group B) - IFX on relapse
Trial: 15037323
Drug: Gatifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin (400 mg)
Trial: 9929929
Drug: Diet with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diet with increased omega-3 PUFA in addition to ibuprofen treatment
Trial: 9929929
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no omega-3 PUFA diet, only ibuprofen)
Trial: 8306366
Drug: IL‐2 i.a.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐2 i.a. infusion for 4 days (Group A, n = 3)
Trial: 8306366
Drug: IFN alpha
RxNorm normalized name: alpha tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN alpha s.c. for 5 days followed by continuous IL‐2 i.v. infusion for 5 days (Group B, n = 4)
Trial: 8306366
Drug: IL‐2 i.v.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL‐2 i.v. infusion for 4 days with s.c. IFN alpha on days 1 and 4 (Group C, n = 4)
Trial: 3378553
Drug: Atropine sulphate
RxNorm normalized name: Atropine sulphate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulphate (same dose as Group 2)
Trial: 3378553
Drug: Glycopyrrolate (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (same dose as Group 2)
Trial: 23826104
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU ergocalciferol daily until delivery
Trial: 23826104
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral bolus of 200,000 IU cholecalciferol
Trial: 24025658
Drug: Medicare Part
RxNorm normalized name: benzocaine / menthol Medicated Pad [Medicaine Sting]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicare Part D prescription drug plan (PDP) with covered drugs
Trial: 24025658
Drug: Medicare Part
RxNorm normalized name: benzocaine / menthol Medicated Pad [Medicaine Sting]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicare Part D prescription drug plan (PDP) with noncovered drugs
Trial: 24025658
Drug: Prior authorization
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior authorization or step therapy for covered drugs
Trial: 24025658
Drug: Medicare Part
RxNorm normalized name: benzocaine / menthol Medicated Pad [Medicaine Sting]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medicare Part D prescription drug plan (PDP)
Trial: 20422423
Drug: 600 μg
RxNorm normalized name: P.G. 600 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 μg misoprostol orally
Trial: 20422423
Drug: 600 μg
RxNorm normalized name: P.G. 600 KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 μg misoprostol rectally
Trial: 16779765
Drug: Playing mahjong
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Playing mahjong twice a week (n = 33)
Trial: 12707981
Drug: Creatine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine (3 g daily for 3 months)
Trial: 10946888
Drug: Continuous GH
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous GH treatment at 33 microg/kg x day
Trial: 10946888
Drug: Continuous GH
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous GH treatment at 67 microg/kg x day
Trial: 10946888
Drug: Discontinuous GH
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuous GH treatment (average dose 32 microg/kg x day over 6 yr)
Trial: 1451716
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg b.d.
Trial: 6207197
Drug: Antithyroid drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid drug and T4 (group I)
Trial: 6207197
Drug: β1‐selective adrenoreceptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β1‐selective adrenoreceptor blocking agent metoprolol (group II)
Trial: 22196428
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy modalities (PT: ultrasound therapy and hot pack)
Trial: 17909308
Drug: Selegiline ODT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline ODT (1.25 mg/d for 6 weeks, then 2.5 mg/d for 6 weeks)
Trial: 14979606
Drug: Vascor (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vascor (test formulation of simvastatin 10 mg)
Trial: 14979606
Drug: Commercially available
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercially available preparation (reference formulation of simvastatin 10 mg)
Trial: 9695205
Drug: Povidone-iodine solution
RxNorm normalized name: POVIDONE-IODINE 1 g in 100 mL TOPICAL LIQUID [Loris Povidone-Iodine Solution]
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Povidone-iodine solution rinsing 4 times daily
Trial: 8590895
Drug: Liposomal melanoma
RxNorm normalized name: melanoma vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal melanoma vaccine combined with low-dose regional IL-2 (arm C)
Trial: 8590895
Drug: Low-dose regional
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose regional IL-2 only (arm D)
Trial: 8590895
Drug: Liposomal melanoma
RxNorm normalized name: melanoma vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal melanoma vaccine alone (arm A)
Trial: 8590895
Drug: Liposomal melanoma
RxNorm normalized name: melanoma vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposomal melanoma vaccine combined with systemic IL-2 (arm B)
Trial: 2666454
Drug: Diltiazem (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (120 mg bid to 180 mg bid)
Trial: 404027
Drug: Limited field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Limited field irradiation followed by MOPP chemotherapy
Trial: 26806185
Drug: Glucosamine sulfate
RxNorm normalized name: Glucosamine Sulfate
DrugBank: Glucosamine (DB01296)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucosamine sulfate (1500mg once daily)
Trial: 25561135
Drug: Phlebodium decumanum
RxNorm normalized name: Phlebodium aureum leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily)
Trial: 25561135
Drug: Phlebodium decumanum
RxNorm normalized name: Phlebodium aureum leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phlebodium decumanum (4 capsules of 400 mg/capsule, daily) plus coenzyme Q10 (4 capsules of 30 mg/capsule, daily)
Trial: 21844282
Drug: Intensive rehabilitation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive rehabilitation treatment (IRT) - 4 weeks of inpatient physical therapy including treadmill and stabilometric platform training.
Trial: 21844282
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received only pharmacological treatment and was invited to practice generic physical exercise at home.
Trial: 17467956
Drug: Dihydrexidine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydrexidine (20 mg subcutaneously)
Trial: 15684319
Drug: Protein supplements
RxNorm normalized name: PROTEIN SUPPLEMENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protein supplements
Trial: 12148107
Drug: Daily short
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily short hemodialysis (DHD; six 2-hour sessions per week)
Trial: 8773035
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Ginkgo biloba extract at 6 hourly intervals along with routine management
Trial: 8773035
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets of same size, shape and colour, given in the same way as Ginkgo biloba
Trial: 2405893
Drug: Transdermal hyoscine
RxNorm normalized name: HYOSCINE HYDROBROMIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal hyoscine (Scopoderm, Ciba‐Geigy)
Trial: 6161281
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment modality (vitrectomy plus photocoagulation)
Trial: 21975269
Drug: Hormonal contraception
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormonal contraception (injectable and oral)
Trial: 15832145
Drug: Weekly physiotherapy
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly physiotherapy
Trial: 2194788
Drug: Fenugreek seeds
RxNorm normalized name: FENUGREEK SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenugreek seeds (100 g, divided into two doses during lunch and dinner)
Trial: 7393831
Drug: Intravenous naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous naloxone administration
Trial: 29232438
Drug: Rituximab as
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab as part of salvage therapy
Trial: 26384447
Drug: TDV (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TDV (various dosages including increased TDV-4 and one-tenth TDV dose)
Trial: 20840689
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing (SRP) plus oral hygiene instruction
Trial: 20840689
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction only (control)
Trial: 20840689
Drug: Successful periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Successful periodontal treatment
Trial: 20840689
Drug: Unsuccessful periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unsuccessful periodontal treatment
Trial: 17547876
Drug: Intravaginal metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravaginal metronidazole gel
Trial: 16389542
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg Delta(9)-tetrahydrocannabinol (dronabinol)
Trial: 26939313
Drug: Seretide (western
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Seretide (western medication)
Trial: 22907998
Drug: Therapeutic hypothermia
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic hypothermia (TH) with cooling gel packs to a target temperature of 33‐34°C for 72 h
Trial: 21212385
Drug: 20 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 Gy of radiation therapy (TE18 trial)
Trial: 21212385
Drug: Para‐aortic radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Para‐aortic radiation therapy (TE10 trial)
Trial: 21212385
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy (TE19 trial)
Trial: 16705841
Drug: Basic treatment
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatment plus acu-moxibustion group (treated with oral medicine like those in the control group plus acupuncture and moxibustion)
Trial: 3327022
Drug: Vincristine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vincristine combination therapy (COP)
Trial: 3327022
Drug: Vindesine combination
RxNorm normalized name: vindesine
DrugBank: Vindesine (DB00309)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindesine combination therapy (CEP)
Trial: 28730676
Drug: Intranasal glucagon
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal glucagon (ING) 1 mg
Trial: 24731783
Drug: Natalizumab treatment
RxNorm normalized name: Natalizumab
DrugBank: Natalizumab (DB00108)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Natalizumab treatment after 6 months
Trial: 24731783
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no natalizumab treatment)
Trial: 23525453
Drug: Intrapleural bevacizumab
RxNorm normalized name: Bevacizumab
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intrapleural bevacizumab (300 mg) with cisplatin (30 mg)
Trial: 23525453
Drug: Intrapleural cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intrapleural cisplatin (30 mg) alone
Trial: 18568412
Drug: Magnesium citrate
RxNorm normalized name: Magnesium Citrate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium citrate (610 mg orally every other day for 2 months)
Trial: 18568412
Drug: Calcium acetate
RxNorm normalized name: Calcium Acetate
DrugBank: Calcium sulfate (DB15533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium acetate therapy (control group)
Trial: 12901032
Drug: Both COX‐2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both COX‐2 inhibitors
Trial: 8972810
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B Plaque Remover (Braun/Oral‐B, Kronberg, Germany)
Trial: 6084675
Drug: Cefazolin 2
RxNorm normalized name: cefazolin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 2 g 1 h pre‐operatively and every 6 h for 48 h (vein graft patients)
Trial: 6084675
Drug: Cefazolin 1
RxNorm normalized name: cefazolin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 1 g (synthetic graft patients)
Trial: 6084675
Drug: Cefazolin 2
RxNorm normalized name: cefazolin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 2 g (synthetic graft patients)
Trial: 27687379
Drug: i-Gel (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-Gel (Group I: n = 17)
Trial: 27687379
Drug: i-Gel (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-Gel (Group I)
Trial: 23424961
Drug: Fluoxetine (Flu)
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (Flu) 20 mg/day
Trial: 18384551
Drug: Nicotine patch
RxNorm normalized name: Nicotine Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine patch (7 mg)
Trial: 18384551
Drug: No patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No patch
Trial: 10674566
Drug: Intranasal budesonide
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal budesonide (400 microg) once daily for 4 weeks
Trial: 10674566
Drug: Aqueous spray
RxNorm normalized name: Pen-Aqueous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aqueous spray (256 microg) once daily for 4 weeks
Trial: 1553856
Drug: 3.125 mg
RxNorm normalized name: carbidopa 3.125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.125 mg intravenous (IV) prochlorperazine
Trial: 3828192
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg oral prochlorperazine
Trial: 3857405
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum (Cp) injections, both intradermal (i.c.) and subcutaneous (s.c.)
Trial: 3857405
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum (Cp) injections
Trial: 23909409
Drug: Alitretinoin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alitretinoin (30 mg oral dose)
Trial: 23909409
Drug: Healthy controls
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy controls (30 mg oral dose of alitretinoin)
Trial: 18672768
Drug: Somiton tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somiton tablet (Control)
Trial: 16204431
Drug: Caffeine 250
RxNorm normalized name: caffeine 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 250 mg at 9:00 AM, 1:00 PM, and 6:00 PM after 5 days of abstinence from caffeine
Trial: 16204431
Drug: Caffeine 300
RxNorm normalized name: caffeine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 300 mg/day and 600 mg/day for 5 days prior to challenge
Trial: 16204431
Drug: Caffeine 0
RxNorm normalized name: caffeine 0.65 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 0 mg (control)
Trial: 12403222
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (iNO) therapy at 20 ppm weaned to 5 ppm over 24-48 hours
Trial: 11760378
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no iNO therapy)
Trial: 10464845
Drug: HFA‐134a BDP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HFA‐134a BDP, 1600 mg total dose
Trial: 10464845
Drug: CFC‐11/12 BDP,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CFC‐11/12 BDP, 2000 mg total dose
Trial: 2284328
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg naftidrofuryl daily per os
Trial: 6776569
Drug: Butoctamide hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butoctamide hydrogen succinate (600 mg)
Trial: 6419633
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg midazolam i.m.
Trial: 6419633
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg midazolam i.m.
Trial: 6419633
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg diazepam i.m.
Trial: 6419633
Drug: 50 mg/50
RxNorm normalized name: Janumet 50 mg/500 mg Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg/50 mg pethidine/promethazine i.m.
Trial: 22040838
Drug: Exercise training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise training with metformin (EM)
Trial: 22040838
Drug: 2,000 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,000 mg/day metformin (M)
Trial: 10664640
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (1.0 and 2.0 g/d of elemental calcium)
Trial: 1616164
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution, 10 mL epidurally and 3 mL intramuscularly (IM)
Trial: 1616164
Drug: 10 mL
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mL of epidural saline solution and 75 mg (3 mL) of diclofenac IM
Trial: 1616164
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of morphine in 10 mL of epidural saline solution and 3 mL of saline solution IM
Trial: 1616164
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of morphine in 10 mL of epidural saline solution and 75 mg of diclofenac IM
Trial: 31141291
Drug: Dynamic navigation
RxNorm normalized name: water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dynamic navigation system for implant placement
Trial: 27050177
Drug: 15ml natural
RxNorm normalized name: Camphor (natural)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15ml natural honey applied on oral mucosa
Trial: 27050177
Drug: 15ml plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15ml plain water applied on oral mucosa (Control)
Trial: 19023841
Drug: Once-daily immunoassay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily immunoassay test strips for urinary cotinine
Trial: 19023841
Drug: Daily multiple
RxNorm normalized name: Daily Multiple Vitamins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multiple CO measurements
Trial: 15841628
Drug: Lidocaine/tetracaine patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/tetracaine patch (30-minute application)
Trial: 12001006
Drug: Metronidazole 1%
RxNorm normalized name: METRONIDAZOLE 1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 1% cream with sunscreen SPF 15
Trial: 8652857
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Interferon-alpha and Hydroxyurea
Trial: 1793694
Drug: Post-operative autotransfusion
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative autotransfusion with pre-operative aspirin
Trial: 1793694
Drug: Post-operative autotransfusion
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative autotransfusion without pre-operative aspirin